NCT00156182View on ClinicalTrials.gov

A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.

PHASE2CompletedINTERVENTIONAL

Enrollment

38

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

December 31, 2001

Study Completion Date

December 31, 2001

Conditions

Leiomyoma

Interventions

DRUG

Asoprisnil

10mg Tablet, oral Daily for 6 months

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Abbott

INDUSTRY